1-(6-Amino-9-methyl-8-pyridin-2-yl-9H-purin-2-ylethynyl)-cyclohexanol

ID: ALA51829

PubChem CID: 10665407

Max Phase: Preclinical

Molecular Formula: C19H20N6O

Molecular Weight: 348.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1c(-c2ccccn2)nc2c(N)nc(C#CC3(O)CCCCC3)nc21

Standard InChI:  InChI=1S/C19H20N6O/c1-25-17(13-7-3-6-12-21-13)24-15-16(20)22-14(23-18(15)25)8-11-19(26)9-4-2-5-10-19/h3,6-7,12,26H,2,4-5,9-10H2,1H3,(H2,20,22,23)

Standard InChI Key:  GKLFVWBVLGOSKV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    5.9542   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5292   -2.8417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9542   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5292   -1.8792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8667   -2.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4417   -2.9667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4417   -1.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9167   -2.0667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9167   -2.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3917   -2.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8625   -3.2566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4667   -2.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3457   -3.5587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7667   -1.8417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4542   -1.1667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7167   -3.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8208   -3.2733    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3667   -1.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8747   -3.8440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8376   -3.8730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7667   -2.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6667   -2.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8461   -4.4730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8915   -4.4438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3667   -2.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3793   -4.7582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  1  0
  5  2  1  0
  6  1  2  0
  7  3  2  0
  8  9  2  0
  9  6  1  0
 10  9  1  0
 11 10  3  0
 12  5  1  0
 13 11  1  0
 14 12  1  0
 15  7  1  0
 16  2  1  0
 17 13  1  0
 18 14  2  0
 19 13  1  0
 20 13  1  0
 21 12  2  0
 22 25  2  0
 23 20  1  0
 24 19  1  0
 25 21  1  0
 26 23  1  0
  4  5  2  0
  7  8  1  0
 18 22  1  0
 26 24  1  0
M  END

Associated Targets(non-human)

Adora2b Adenosine A2b receptor (205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 348.41Molecular Weight (Monoisotopic): 348.1699AlogP: 2.05#Rotatable Bonds: 1
Polar Surface Area: 102.74Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.97CX Basic pKa: 3.57CX LogP: 2.84CX LogD: 2.84
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.65Np Likeness Score: -0.44

References

1. Harada H, Asano O, Hoshino Y, Yoshikawa S, Matsukura M, Kabasawa Y, Niijima J, Kotake Y, Watanabe N, Kawata T, Inoue T, Horizoe T, Yasuda N, Minami H, Nagata K, Murakami M, Nagaoka J, Kobayashi S, Tanaka I, Abe S..  (2001)  2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.,  44  (2): [PMID:11170626] [10.1021/jm990499b]

Source